Company Filing History:
Years Active: 2016
Title: Manuela Mura: Innovator in Tumor Angiogenesis Inhibition
Introduction
Manuela Mura is a prominent inventor based in Birmingham, GB. She has made significant contributions to the field of cancer research, particularly in the area of tumor angiogenesis. Her innovative work has led to the development of a unique method for inhibiting tumor growth.
Latest Patents
Manuela Mura holds a patent for "CLEC14A inhibitors - A method of inhibiting tumor angiogenesis in an individual." This method involves administering an inhibitor of CLEC14A, which may be an antibody, an siRNA molecule, an antisense molecule, or a ribozyme. This patent represents a crucial advancement in cancer treatment strategies.
Career Highlights
Throughout her career, Manuela has been associated with Cancer Research Technology Limited, where she has focused on developing therapeutic solutions for cancer patients. Her dedication to research and innovation has positioned her as a key figure in her field.
Collaborations
Manuela has collaborated with notable colleagues, including Roy Bicknell and Xiaodong Zhuang. These partnerships have enhanced her research efforts and contributed to the advancement of cancer therapies.
Conclusion
Manuela Mura's work in inhibiting tumor angiogenesis showcases her commitment to improving cancer treatment. Her innovative approach and collaboration with esteemed colleagues highlight her significant impact in the field of cancer research.